<?xml version="1.0" encoding="UTF-8"?>
<p>Most common commercial Valerian preparations are generally quite safe for short-term use (for 4â€“6 weeks), 600 mg of valerian did not cause clinically significant effects on reaction time, alertness, and concentration the morning after ingestion [
 <xref rid="B167-plants-10-00846" ref-type="bibr">167</xref>]. No literature data is available that demonstrated the safety of long term use. In addition, little is known about their use in the woman during pregnancy and nursing and in children younger than 3 years old. However, the few side effects reported in the literature include agitation, restlessness, insomnia, headache, dizziness, itching and gastrointestinal upset. Particular attention must be paid to the potential interactions with sedative substances such as barbiturates, benzodiazepine, melatonin, alcohol, some herbs and dietary supplements with sedative properties (
 <italic>Hypericum perforatum</italic> L., 
 <italic>Piper methysticum</italic> G. Forst) due to the potential additive effects. Cytotoxicity was detected only in vitro for valepotriates with no carcinogenic effects in animal models. These compounds are not always present in commercial valerian preparations. There is report that the roots and rhizomes of 
 <italic>Valeriana officinalis</italic> have been used in official medicine in the form of various dosage for more than 240 years [
 <xref rid="B175-plants-10-00846" ref-type="bibr">175</xref>]. Moreover, Valeriana drugs in Russian medicine are used in mono form, which increases the importance of this plant for the treatment of a wide range of diseases [
 <xref rid="B175-plants-10-00846" ref-type="bibr">175</xref>]. Despite the wide use of these herbs in traditional medicine as well in the official medicine, more advanced clinical studies are still necessary on other plant species of this subfamily to establish the numerous biological activities associated with their pharmacological applications.
</p>
